Clinical Trial Update: Study to Evaluate the Safety and Efficacy of CJ-30060 in Hypertensive Patients With Hyperlipidemia [Phase 3]

View source ↗

Summary

Phase 3 study CJ-30060 in hypertensive patients with hyperlipidemia has completed its trial, evaluating safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia
• Hypertension

Drugs mentioned

• CJ-30060

Snippet

Sponsor: HK inno.N Corporation | Conditions: Hypertension With Hyperlipidemia | Phase 3 | Status: COMPLETED